comprehensive -WSS

comprehensive

author：fashion 2025-10-02 22:56:36 - browse：37

Photo illustration of a checkbook wrapped with lock and chain – hospital and investment coverage from STAT — Alex Hogan/STAT

Hospitals once dove headfirst into venture capital with splashy headlines and attention-grabbing numbers. Now, in an era of flattened margins and exceedingly uncertain returns, many health systems are quietly pulling back.

NewYork-Presbyterian’s venture firm, once managing roughly $40 million in assets, was essentially dissolved, two former employees said, with leaders punting it from the system’s strategy division to innovation, then from innovation to the investment office — a spokesperson described it as being “integrated” into the broader strategy. PitchBook data show no investments after 2020.

Advocate Health Enterprises, meanwhile, the venture firm of a 67-hospital system based in Charlotte, N.C., has lost at least six employees within the past year, including its president, from a staff that once included about a dozen people.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Trans patients at the end of life deserve respect and dignity

WSS

DeSantis wants to import drugs. Biden’s FDA blasted his plan

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

Anthos stroke drug appears safer than common blood thinner

Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

Poor hospice wound care hurts patients and families

Roche's accidental data boosts hopes for anti

focus

comprehensive

knowledge

As demand for Covid shots wanes, Moderna seeks its next success

Roche's accidental data boosts hopes for anti

Supreme Court strikes down use of affirmative action

Wegovy improves function in certain heart failure patients

In age of alternative facts, a scholarly course on calling out crap

What past blockbusters can tell us about future of Wegovy and other weight loss medicines

Bright Health sells Medicare Advantage business to Molina

Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc

Medicare proposal to cover medical devices draws a mixed reaction

A daunting task: navigating dual Medicare, Medicaid eligibility

explore

Meadows told special counsel he could not recall Trump ever declassifying Mar

DeSantis wants to import drugs. Biden’s FDA blasted his plan

A daunting task: navigating dual Medicare, Medicaid eligibility

Listen: Vivek Ramaswamy's star turn & leaky drug data

Republicans love RFK Jr. What's that tell us about health in 2024?

PBMs are inflating the cost of generic drugs. They must be reined in

knowledge

hotspot

focus

hotspot